WHO shows interest in Guj's SMS model to check fake medicines

Image
Press Trust of India Ahmedabad
Last Updated : Jan 21 2013 | 5:46 PM IST

As part of its e-governance initiative, the Gujarat Food and Drug Control Administration (FDCA) had developed an SMS alert system through which all the stakeholders in the state could be notified of the recalled fake drugs.

This cost-effective model was launched in the state earlier this year to protect the patients from spurious drugs.

"WHO has evinced interest in Gujarat's SMS recall model for the spurious drugs. It plans to implement this cost- effective model for patient safety in the developing countries," Gujarat FDCA Commissioner H G Koshia said.

"We have submitted a concept note of this model to them, after the recent visit of Dr Veer Surya from WHO headquarters to Gujarat's FDCA," he said.

Commenting on the model, Dr Surya had said that it was a viable tool to protect the patients' health and could be implemented in the developing countries, Koshia said.

This model has also been appreciated and praised by top executives of global pharma giants like US-based Abott Laboratories and Israel-based Teva Pharmaceutical.

WHO is the directing and coordinating authority for health within the United Nation system, with over 150 countries as its members.

Several Indian states are also in the process of replicating this model.

The system has issued around 60 alerts so far on sub-standards drugs detected during random sampling done by the FDCA, asking chemists to stop the sale of such spurious medicine.

  

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 06 2012 | 4:55 PM IST

Next Story